← Leaderboards
Susan E Quaggin
Mt Sinai Hosp-Samuel Lunenfeld Res Inst
$9,714,173
Attributed
$10,897,492
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,817,230 · 10
By mechanism
R01$8,385,352 · 3
P30$6,858,262 · 2
U54$3,777,444 · 2
U2C$2,254,000 · 1
T32$342,172 · 1
R21$200,000 · 1
Top collaborators
- Alfred L George7 shared
- David J Klumpp5 shared
- James P Lash5 shared
- Karl A Scheidt5 shared
- Jing Jin4 shared
- Eun Ji Paige Chung1 shared
- Pinelopi P. Kapitsinou1 shared
Others in their field
Top investigators on “Kidney”
- Jeffrey P Krischer · University Of South Florida$540,222,210
- John M Lachin · George Washington University$155,894,464
- David M Nathan · Massachusetts Institute Of Technology$127,229,266
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$111,521,899
- David Heimbrook · Leidos Biomedical Research, Inc.$83,221,586
- Peter Scott Heeger · Case Western Reserve University$80,562,246
Research focus
KidneyDesignFundingAffectCollaborationsPathogenesisLeadResearch PersonnelProgramsEducational WorkshopResourcesUniversitiesInnovationEventNovel TherapeuticsPathway InteractionsSignal TransductionPhenotypeCellsBaseInternationalMolecularLinkSignal Pathway
Grant awards (41)
Northwestern University O'Brien Kidney National Resource Center$957,137
U54 · FY2025 · DK · contact PI
Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)$460,000
U2C · FY2025 · DK · contact PI
Administrative Core$319,046
U54 · FY2025 · DK · contact PI
Northwestern University O'Brien Kidney National Resource Center$982,232
U54 · FY2024 · DK · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$600,978
R01 · FY2024 · EY · contact PI
Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)$414,000
U2C · FY2024 · DK · contact PI
Administrative Core$196,292
U54 · FY2024 · DK · contact PI
Northwestern University O'Brien Kidney National Resource Center$992,052
U54 · FY2023 · DK · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$600,978
R01 · FY2023 · EY · contact PI
Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)$460,000
U2C · FY2023 · DK · contact PI
Pathogenesis of Diabetic Nephropathy$355,500
R01 · FY2023 · DK · contact PI
Administrative Core$330,685
U54 · FY2023 · DK · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,120,048
P30 · FY2022 · DK · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$582,949
R01 · FY2022 · EY · contact PI
Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)$460,000
U2C · FY2022 · DK · contact PI
Pathogenesis of Diabetic Nephropathy$355,500
R01 · FY2022 · DK · contact PI
Administrative Core$224,788
P30 · FY2022 · DK · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,133,852
P30 · FY2021 · DK · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$581,733
R01 · FY2021 · EY · contact PI
Chicago Kidney Urology Hematology network FOR city-Wide reseArch tRaining and career Development (Chicago KUH FORWARD)$460,000
U2C · FY2021 · DK · contact PI
Administrative Core$224,789
P30 · FY2021 · DK · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,145,719
P30 · FY2020 · DK · contact PI
Activation of the Angiopoietin-Tie2/TEK Pathway to Treat Ocular Hypertension and Glaucoma$617,955
R01 · FY2020 · EY · contact PI
Pathogenesis of Diabetic Nephropathy$355,500
R01 · FY2020 · DK · contact PI
Administrative Core$224,790
P30 · FY2020 · DK · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,155,697
P30 · FY2019 · DK · contact PI
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma$695,357
R01 · FY2019 · EY · contact PI
Administrative Core$224,790
P30 · FY2019 · DK · contact PI
Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases$1,179,001
P30 · FY2018 · DK · contact PI
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma$695,357
R01 · FY2018 · EY · contact PI
Administrative Core$224,788
P30 · FY2018 · DK · contact PI
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma$695,357
R01 · FY2017 · EY · contact PI
Exploiting Tie2 Activation for the Treatment of Vascular Diseases$386,250
R01 · FY2017 · HL · contact PI
NUKIDs: Scientist Training Program in Kidney Disease$210,477
T32 · FY2017 · DK · contact PI
Activation of the Angiopoietin-Tie2 Pathway to Treat Ocular Hypertension and Glaucoma$708,982
R01 · FY2016 · EY · contact PI
Exploiting Tie2 Activation for the Treatment of Vascular Diseases$386,250
R01 · FY2016 · HL · contact PI
NUKIDs: Scientist Training Program in Kidney Disease$131,695
T32 · FY2016 · DK · contact PI
Exploiting Tie2 Activation for the Treatment of Vascular Diseases$380,456
R01 · FY2015 · HL · contact PI
Exploiting Tie2 Activation for the Treatment of Vascular Diseases$386,250
R01 · FY2014 · HL · contact PI
PODOCYTE CELL LINEAGE IN GENITOURINARY DEVELOPMENT$100,000
R21 · FY2001 · DK
PODOCYTE CELL LINEAGE IN GENITOURINARY DEVELOPMENT$100,000
R21 · FY2000 · DK